Home News

2017 first half results presentation

Operating revenues, growth data, profitability and the behavior of our products.

Wed, 26/07/2017 - 12:28 0 min
Download related document
No votes yet
 
Related
ROVI announces the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union
ROVI announces the commencement of the assessment process to obtain marketing...
ROVI filed its application for marketing authorisation for Doria® with the European health authorities, the European Medicines Agency (EMA...
2 min
31/01/2020
2019 Investor Day presentation
0 min
25/11/2019
Financial Results Nine month period 2019 - Video
0 min
25/11/2019